7. A CASE STUDY OF AIRWAY STENOSIS DUE TO ISONIAZIDAND LEVOFLOXACIN-RESISTANT TUBERCULOSIS IN NATIONAL LUNG HOSPITAL, 2023

Ha Thi Tuyet Trinh1
1 National Lung Hospital

Main Article Content

Abstract

We report a case of Endobronchial Tuberculosis in a 17-year-old female patient with drug resistance to Isoniazid, Levofloxacin (INH, Lfx). The diagnosis was based on computerizedtomography, bronchoscopy and culture. This is a case of late diagnosis, with symptoms similar to other respiratory diseases. The patient had good clinical response tomedical treatment.

Article Details

References

[1] World Health Organisation. Global tuberculosis
report 2023. Available online: Http://apps.who.int/
iris/bitstream/10665/191102/1/9789241565059_
eng.pdf.
[2] Trịnh Bỉnh Dy, Bài giảng sinh lý học, Nhà xuất
bản Y học, 1998.
[3] Kim Y et al., Changes in the levels of interferon-
gamma and transforming growth factor-beta
influence bronchial stenosis during the treatment
of endobronchial tuberculosis. Respiration 74,
202–207, 2007.
[4] Freitag L, Ernst A, Unger M et al., A proposed
classification system of central airway stenosis.
Eur Respir J 30, 7–12, 2007.
[5] Cotton RT, Pediatric laryngotracheal stenosis. J
Pediatr Surg 19, 699–704, 1984.
[6] Jung SS, Park HS, Kim JO et al., Incidence and
clinical predictors of endobronchial tuberculosis
in patients with pulmonary tuberculosis. Respirology
20, 488–495, 2015.
[7] Montani D. CT of the Airways. Eur Respir Rev.
2011 Mar;20(119):65. PMCID: PMC9487721.
[8] Im JG, Itoh H, Han MC, CT of pulmonary tuberculosis.
Semin Ultrasound CT MR 16, 420–434,1995.
[9] Cohen MD, Weber TR, Rao CC, Balloon dilatation of
tracheal and bronchial stenosis. AJR Am J Roentgenol
142, 477–478, 1984.